GlassScriptPhysician profile
Deepak Padmanabha
NPI 1639563109
$13,067.88
in general payments reported to CMS, 2019-2025
15 companies · $650 in 2025
The $650 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $6,888 · 2021: $1,251 · 2022: $2,078 · 2023: $1,185 · 2024: $916 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $5,000.00 | 2020 | |
| Abbott Laboratories | $3,356.86 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,667.00 | 2020 | |
| Nevro Corp. | $1,520.30 | 2020-2024 | Senza |
| Nalu Medical, INC. | $752.53 | 2022-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $303.78 | 2021-2025 | Inceptiv, Kyphon Express II Kyphopak Tray |
| Stratus Medical, LLC | $114.75 | 2022 | |
| Alkermes, INC. | $101.46 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $63.95 | 2025 | |
| Globus Medical, INC. | $46.84 | 2025 | Senza |
| Stryker Corporation | $38.50 | 2022 | |
| Coherus Oncology, INC. | $32.88 | 2023 | |
| Avanos Medical | $29.98 | 2024 | Generator |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.23 | 2025 | Ofev |
| Curonix LLC | $18.82 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Padmanabha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.